Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb has announced its new-look leadership after the Celgene takeover goes through, and it reveals a mixed bag of new hires, sideways moves, and departures. The headline news is that ...

Superlatives are tricky things. [mircemk]’s guide “How to make Simplest ever Oscilloscope Clock” falls into that category. It’s that word, simplest. Certainly, this is an oscilloscope clock, and a ...

Just bought used. Interior and exterior awesome. Engine strong. Nice ride, quiet inside. One common issue, water leak driver side door. Which will be fixed. Jeep runs great and the lift and tires put ...